Orod Osanlou - Bangor University, Betsi Cadwaladr University Health Board

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 32 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Optimal Dose and Safety of Intravenous Favipiravir in Hospitalised Patients with SARS-CoV-2 Infection: a Phase Ib, Open-Label, Dose-Escalating, Randomised Controlled Study

Tim Rowland, Richard FitzGerald, Elizabeth Challenger,Laura Dickinson,Laura Else,Lauren Walker,Colin Hale, Victoria Shaw, Callum Kelly, Rebecca Lyon, Jenn Gibney, Karim Dhamani, Margaret Irwin, Yvanne Enever,Michelle Tetlow, William Wood,Helen Reynolds,Justin Chiong,Orod Osanlou,Henry Pertinez, Katie Bullock, William Greenhalf,Andrew Owen, David G Lalloo,Michael Jacobs, Julian A Hiscox,Thomas Jaki,Pavel Mozgunov,Geoff Saunders,Gareth Griffiths, Saye H Khoo, Tom Fletcher, the AGILE CST-6 study group

medrxiv（2025）

Cited0Views0Bibtex

Optimal Dose and Safety of Intravenous Favipiravir in Hospitalized Patients with SARS-COV-2: A Phase I, Open-Label, Dose-Escalating, Randomized Controlled Study

Tim Rowland,Richard FitzGerald,Laura Else,Elizabeth Challenger,Laura Dickinson,Lauren Walker,Colin Hale,Rebecca Lyon, Karim Dhamani, Margaret Irwin,Yvanne Enever,Michelle Tetlow,Orod Osanlou,Helen Reynolds,Justin Chiong,Henry Pertinez,Andrew Owen,Geoff Saunders,Gareth Griffiths,Saye Khoo,Tom Fletcher

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2024): 8-9

Cited0Views0Bibtex

The Predictive Role of Symptoms in COVID-19 Diagnostic Models: A Longitudinal Insight

Epidemiology and Infection (2024)

Cited2Views0WOSBibtex

2346. Preliminary Results of Durable Immune Response Induced by a Self-Amplifying Mrna (samrna) SARS-CoV-2 Vaccine Candidate, GRT-R910, in Adults Previously Vaccinated with Mrna or AZD1222 Primary Series

Alison Uriel,Pedro Garbes, A Nagare, J C Kuan,Christine Palmer,K Bae,Karin Jooss,A Rappaport,Melissa Kachura, L Kraemer,Harshni Venkatraman,Jason Jaroslavsky,Sonia Kounlavouth,M Marrali,Meghan Hart, J Betular, A Allen, C Green,O Osanlou,Adrian Palfreeman, Tolga Turgut,Andrew Ustianowski

Open Forum Infectious Diseasesno. Supplement_2 (2023)

Cited0Views0Bibtex

Safety and Efficacy of the NVX-CoV2373 Coronavirus Disease 2019 Vaccine at Completion of the Placebo-Controlled Phase of a Randomized Controlled Trial

CLINICAL INFECTIOUS DISEASES（2023）

Cited30Views0WOSBibtex

Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial (vol 84, pg 795, 2022)

Xinxue Liu,Alasdair P. S. Munro,Shuo Feng,Leila Janani,Parvinder K. Aley,Gavin Babbage,David Baxter,Marcin Bula,Katrina Cathie,Krishna Chatterjee,Wanwisa Dejnirattisai,Kate Dodd,Yvanne Enever,Ehsaan Qureshi,Anna L. Goodman,Christopher A. Green,Linda Harndahl,John Haughney,Alexander Hicks,Agatha A. van der Klaauw,Jonathan Kwok,Vincenzo Libri,Martin J. Llewelyn,Alastair C. McGregor,Angela M. Minassian,Patrick Moore,Mehmood Mughal,Yama Mujadidi,Kyra Holliday,Orod Osanlou,Rostam Osanlou,Daniel R. Owens,Mihaela Pacurar,Adrian Palfreeman,Daniel Pan,Tommy Rampling,Karen Regan,Stephen Saich,Teona Serafimova,Dinesh Saralaya,Gavin R. Screaton,Sunil Sharma,Ray Sheridan,Ann Sturdy,Piyada Supasa,Emma C. Thomson,Shirley Todd,Chris Twelves,Robert C. Read,Sue Charlton,Bassam Hallis,Mary Ramsay,Nick Andrews,Teresa Lambe,Jonathan S. Nguyen-Van-Tam,Victoria Cornelius,Matthew Snape,Saul N. Faust

JOURNAL OF INFECTION（2023）

Cited0Views0Bibtex

Persistence of Immune Responses after Heterologous and Homologous Third COVID-19 Vaccine Dose Schedules in the UK: Eight-Month Analyses of the COV-BOOST Trial

Xinxue Liu, Annie Wright,Shuo Feng,Leila Janani,Parvinder K. Aley,Gavin Babbage,Jonathan Baker,David Baxter,Tanveer Bawa,Marcin Bula,Katrina Cathie,Krishna Chatterjee,Kate Dodd,Yvanne Enever,Lauren Fox,Ehsaan Qureshi,Anna L. Goodman,Christopher A. Green,John Haughney,Alexander Hicks,Christine E. Jones,Nasir Kanji,Agatha A. van der Klaauw,Vincenzo Libri,Martin J. Llewelyn, Rebecca Mansfield,Mina Maallah,Alastair C. McGregor,Angela M. Minassian,Patrick Moore,Mehmood Mughal,Yama F. Mujadidi, Hanane Trari Belhadef,Kyra Holliday,Orod Osanlou,Rostam Osanlou,Daniel R. Owens,Mihaela Pacurar,Adrian Palfreeman,Daniel Pan,Tommy Rampling,Karen Regan,Stephen Saich,Dinesh Saralaya,Sunil Sharma,Ray Sheridan, Matthew Stokes,Emma C. Thomson,Shirley Todd,Chris Twelves,Robert C. Read,Sue Charlton,Bassam Hallis,Mary Ramsay,Nick Andrews,Teresa Lambe,Jonathan S. Nguyen-Van-Tam,Victoria Cornelius,Matthew Snape,Saul N. Faust

Journal of Infectionno. 1 (2023): 18-26

Cited17Views0WOSBibtex

Persistence of Immunogenicity after Seven COVID-19 Vaccines Given As Third Dose Boosters Following Two Doses of ChAdOx1 Ncov-19 or BNT162b2 in the UK: Three Month Analyses of the COV-BOOST Trial

Xinxue Liu,Alasdair P. S. Munro,Shuo Feng,Leila Janani,Parvinder K. Aley,Gavin Babbage,David Baxter,Marcin Bula,Katrina Cathie,Krishna Chatterjee,Wanwisa Dejnirattisai,Kate Dodd,Yvanne Enever,Ehsaan Qureshi,Anna L. Goodman,Christopher A. Green,Linda Harndahl,John Haughney,Alexander Hicks,Agatha A. van der Klaauw,Jonathan Kwok,Vincenzo Libri,Martin J. Llewelyn,Alastair C. McGregor,Angela M. Minassian,Patrick Moore,Mehmood Mughal,Yama F. Mujadidi,Kyra Holliday,Orod Osanlou,Rostam Osanlou,Daniel R. Owens,Mihaela Pacurar,Adrian Palfreeman,Daniel Pan,Tommy Rampling,Karen Regan,Stephen Saich,Teona Serafimova,Dinesh Saralaya,Gavin R. Screaton,Sunil Sharma,Ray Sheridan,Ann Sturdy,Piyada Supasa,Emma C. Thomson,Shirley Todd,Chris Twelves,Robert C. Read,Sue Charlton,Bassam Hallis,Mary Ramsay,Nick Andrews,Teresa Lambe,Jonathan S. Nguyen-Van-Tam,Victoria Cornelius,Matthew D. Snape,Saul N. Faust

JOURNAL OF INFECTION（2022）

Cited48Views0WOSBibtex

Immunogenicity and Reactogenicity of BNT162b2 and mRNA1273 COVID-19 Vaccines Given as Fourth Dose Boosters in the COV-BOOST Randomised Trial Following Two Doses of ChAdOx1 nCov-19 or BNT162b2 and a Third Dose of BNT162b2

Alasdair P.S Munro,Shuo Feng,Leila Janani,Victoria Cornelius,Parvinder K. Aley,Gavin Babbage,David Baxter,Marcin Bula,Katrina Cathie,Krishna Chatterjee,Kate Dodd,Yvanne Enever,Ehsaan Qureshi,Anna L. Goodman,Christopher A. Green,Linda Harndahl,John Haughney,Alexander Hicks,Agatha A. van der Klaauw,Nasir Kanji,Vincenzo Libri,Martin J. Llewelyn,Alastair C. McGregor,Angela M. Minassian,Patrick Moore,Mehmood Mughal,Yama Farooq Mujadidi,Kyra Holliday,Orod Osanlou,Rostam Osanlou,Daniel R. Owens,Mihaela Pacurar,Adrian Palfreeman,Daniel Pan,Tommy Rampling,Karen Regan,Stephen Saich,Tanveer Bawa,Dinesh Saralaya,Sunil Sharma,Ray Sheridan, Mina Maalah,Emma C. Thomson,Shirley Todd,Chris Twelves,Robert C. Read,Sue Charlton,Bassam Hallis,Mary E. Ramsay,Nick Andrews,Teresa Lambe,Jonathan S. Nguyen-Van-Tam,Matthew D. Snape,Xinxue Liu,Saul N. Faust

Social Science Research Network (2022)

Cited0Views0Bibtex

Safety, Immunogenicity, and Reactogenicity of BNT162b2 and Mrna-1273 COVID-19 Vaccines Given As Fourth-Dose Boosters Following Two Doses of ChAdOx1 Ncov-19 or BNT162b2 and a Third Dose of BNT162b2 (COV-BOOST): a Multicentre, Blinded, Phase 2, Randomised Trial

The Lancet Infectious Diseases（2022）

Cited122Views0WOSBibtex

122

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn